ABCB1 and chronic myelogenous leukemia, BCR-ABL1 positive: Although these previously described works do not identify the role of ABCB1 in imatinib resistance, studies in polymorphisms of ABCB1 have shown the importance of ABCB1 in CML treatment resistance.